These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 17205524)
1. Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells. Pinto JT; Sinha R; Papp K; Facompre ND; Desai D; El-Bayoumy K Int J Cancer; 2007 Apr; 120(7):1410-7. PubMed ID: 17205524 [TBL] [Abstract][Full Text] [Related]
2. Effects of naturally occurring and synthetic organoselenium compounds on protein profiling in androgen responsive and androgen independent human prostate cancer cells. Sinha R; Pinto JT; Facompre N; Kilheffer J; Baatz JE; El-Bayoumy K Nutr Cancer; 2008; 60(2):267-75. PubMed ID: 18444160 [TBL] [Abstract][Full Text] [Related]
3. 1,4-phenylenebis(methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells. Facompre ND; El-Bayoumy K; Sun YW; Pinto JT; Sinha R Cancer Prev Res (Phila); 2010 Aug; 3(8):975-84. PubMed ID: 20606040 [TBL] [Abstract][Full Text] [Related]
4. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076 [TBL] [Abstract][Full Text] [Related]
5. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer. Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058 [TBL] [Abstract][Full Text] [Related]
6. [Expression and regulation of androgen receptor in the androgen-independent conversion of prostate cancer cells]. Wang HF; Liu WJ; Jin J; Zhou LQ; Liang LL; Wang Y; Guo YL Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):490-5. PubMed ID: 21844951 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens. Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968 [TBL] [Abstract][Full Text] [Related]
8. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040 [TBL] [Abstract][Full Text] [Related]
9. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Culig Z; Hobisch A; Cronauer MV; Radmayr C; Trapman J; Hittmair A; Bartsch G; Klocker H Cancer Res; 1994 Oct; 54(20):5474-8. PubMed ID: 7522959 [TBL] [Abstract][Full Text] [Related]
10. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models. Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223 [TBL] [Abstract][Full Text] [Related]
11. Gum mastic inhibits the expression and function of the androgen receptor in prostate cancer cells. He ML; Yuan HQ; Jiang AL; Gong AY; Chen WW; Zhang PJ; Young CY; Zhang JY Cancer; 2006 Jun; 106(12):2547-55. PubMed ID: 16691616 [TBL] [Abstract][Full Text] [Related]
12. Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription. Cho SD; Jiang C; Malewicz B; Dong Y; Young CY; Kang KS; Lee YS; Ip C; Lü J Mol Cancer Ther; 2004 May; 3(5):605-11. PubMed ID: 15141018 [TBL] [Abstract][Full Text] [Related]
13. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP. Fujinami K; Uemura H; Ishiguro H; Kubota Y Int J Mol Med; 2002 Aug; 10(2):173-6. PubMed ID: 12119554 [TBL] [Abstract][Full Text] [Related]
14. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice. Jin RJ; Wang Y; Masumori N; Ishii K; Tsukamoto T; Shappell SB; Hayward SW; Kasper S; Matusik RJ Cancer Res; 2004 Aug; 64(15):5489-95. PubMed ID: 15289359 [TBL] [Abstract][Full Text] [Related]
16. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms. Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539 [TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines. Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines. Tørring N; Jørgensen PE; Sørensen BS; Nexø E Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639 [TBL] [Abstract][Full Text] [Related]
19. Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line. Wang LG; Ossowski L; Ferrari AC Cancer Res; 2001 Oct; 61(20):7544-51. PubMed ID: 11606392 [TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP. Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]